Cytosorbents Corporation (CTSO) financial statements (2020 and earlier)

Company profile

Business Address 7 DEER PARK DRIVE, SUITE K
MONMOUTH JUNCTION, NJ 08852
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1222175862
Cash and cash equivalents1222175542
Short-term investments    22 
Receivables44211  
Inventory, net of allowances, customer advances and progress billings2111110
Inventory2111110
Other undisclosed current assets2100121
Total current assets:21282181083
Noncurrent Assets
Operating lease, right-of-use asset1
Property, plant and equipment2211100
Intangible assets, net (including goodwill)     1
Intangible assets, net (excluding goodwill)     1 
Other noncurrent assets3321110
Other undisclosed noncurrent assets     (1) 
Total noncurrent assets:6432111
TOTAL ASSETS:273324101184
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3222141
Accounts payable2111111
Accrued liabilities100003 
Interest and dividends payable0000   
Deferred revenue0
Debt2141  2
Deferred revenue and credits   00
Customer advances and deposits0 00
Contract with customer, liability0
Other undisclosed current liabilities5423200
Total current liabilities:10786353
Noncurrent Liabilities
Long-term debt and lease obligation14964   
Long-term debt, excluding current maturities13964   
Operating lease, liability1
Total noncurrent liabilities:14964   
Total liabilities:24161410353
Stockholders' equity
Stockholders' equity attributable to parent, including:31710(0)84(14)
Preferred stock      0
Common stock0000000
Additional paid in capital19218616314314012891
Accumulated other comprehensive income (loss)10(0)110(0)
Accumulated deficit(189)(170)(152)(144)(133)(124) 
Other undisclosed stockholders' equity attributable to parent      (106)
Other undisclosed stockholders' equity      15
Total stockholders' equity:31710(0)841
TOTAL LIABILITIES AND EQUITY:273324101184

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues25231510542
Revenue, net1510542
Cost of revenue
(Cost of Goods and Services Sold)
(7)(7)(6)(4)(2)(2)(2)
Other undisclosed gross profit     00
Gross profit:1815106321
Operating expenses(37)(31)(19)(17)(12)(9)(5)
Operating loss:(19)(16)(10)(11)(9)(7)(5)
Nonoperating income (expense)(1)(2)1(1)1(2)(0)
Foreign currency transaction gain (loss), before tax(0)(1)1(0)(1)0 
Debt instrument, convertible, beneficial conversion feature      0
Interest and debt expense     (0) 
Other undisclosed income from continuing operations before equity method investments, income taxes     0 
Loss from continuing operations before income taxes:(20)(18)(9)(12)(8)(10)(5)
Income tax benefit1110000
Net loss attributable to parent:(19)(17)(8)(12)(8)(9)(5)
Preferred stock dividends and other adjustments  (0)  (9)(2)
Net loss available to common stockholders, diluted:(19)(17)(9)(12)(8)(19)(7)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss:(19)(17)(8)(12)(8)(9)(5)
Other comprehensive income (loss)     0(0)
Comprehensive loss:(19)(17)(8)(12)(8)(9)(5)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent01(1)00  
Comprehensive loss, net of tax, attributable to parent:(19)(17)(10)(12)(8)(9)(5)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: